<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03912688</url>
  </required_header>
  <id_info>
    <org_study_id>XJA-S-20190212</org_study_id>
    <nct_id>NCT03912688</nct_id>
  </id_info>
  <brief_title>TEAS Reduces Remifentanil Consumption</brief_title>
  <acronym>TRIM</acronym>
  <official_title>Effect of Transcutaneous Electrical Acupoint Stimulation on Remifentanil Consumption and Postoperative Pain in Patients Undergoing Radical Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcutaneous electrical acupoint stimulation (TEAS) has been shown to decrease the need of
      opioids including remifentanil during anaesthesia. However, it is not clear whether
      combination of two or more acupoints could induce stronger analgesia. Moreover, evidence for
      the long-term effect of TEAS has been limited. The present study was to compare the
      short-term and long-term effect on pain of dual-acupoint and single-acupoint TEAS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Interventions were performed by a designated investigator who was not involved in the anaesthesia or the follow-up. The stimulator was placed in an opaque box to blind the surgical team and the anesthesiologists to the group allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>consumption of remifentanil</measure>
    <time_frame>from start of anesthesia to extubation, on average 2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to recall</measure>
    <time_frame>from end of remifentanil infusion to patient response to verbal command,approximately 10 minutes on average</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to extubation</measure>
    <time_frame>from end of remifentanil infusion to extubation,approximately 10 minutes on average</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory depression</measure>
    <time_frame>end of the surgery to discharge from postanesthesia care unit,with an average of 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea and vomiting</measure>
    <time_frame>end of the surgery to discharge from postanesthesia care unit,with an average of 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale of pain</measure>
    <time_frame>end of the surgery to discharge from postanesthesia care unit,with an average of 30 minutes</time_frame>
    <description>pain intensity is assessed by a 0-10mm scale, 0 is no pain, 10 is untolerated pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients' satisfaction score</measure>
    <time_frame>from end of surgery to 24 hours after surgery, totally 24 hours</time_frame>
    <description>patients' satisfaction score is assessed by a 0-10mm scale, 0 is no pain, 10 is untolerated pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of pain at 3m after surgery</measure>
    <time_frame>from discharge from hospital to 3 months after surgery, approximately 3 months</time_frame>
    <description>percentage of patients suffering from pain around the incision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of pain at 6m after surgery</measure>
    <time_frame>from discharge from hospital to 6 months after surgery, approximately 3 months</time_frame>
    <description>percentage of patients suffering from pain around the incision</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>single acupoint stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dual acupoints stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>no stimulation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupoint stimulation</intervention_name>
    <arm_group_label>dual acupoints stimulation</arm_group_label>
    <arm_group_label>single acupoint stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>single acupoint</intervention_name>
    <arm_group_label>single acupoint stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dual acupoints</intervention_name>
    <arm_group_label>dual acupoints stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 65 yrs

          -  body mass index (BMI) of 18 to 30 kg/m2

          -  elective radical mastectomy under general anaesthesia

        Exclusion Criteria:

          -  contradictions to TEAS

          -  difficulties in communication

          -  histories of general anaesthesia

          -  drug or alcohol abuse or addiction

          -  cardiac dysfunction or severe hypertension

          -  confirmed hepatic dysfunction and renal impairment

          -  the participants recruited into other clinical trials during last three months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Kuhn LA. Editorial: Acupuncture anesthesia for open heart surgery. Am J Cardiol. 1974 Aug;34(2):254-5.</citation>
    <PMID>4843161</PMID>
  </reference>
  <results_reference>
    <citation>Lu Z, Dong H, Wang Q, Xiong L. Perioperative acupuncture modulation: more than anaesthesia. Br J Anaesth. 2015 Aug;115(2):183-93. doi: 10.1093/bja/aev227. Review.</citation>
    <PMID>26170347</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang H, Xie Y, Zhang Q, Xu N, Zhong H, Dong H, Liu L, Jiang T, Wang Q, Xiong L. Transcutaneous electric acupoint stimulation reduces intra-operative remifentanil consumption and alleviates postoperative side-effects in patients undergoing sinusotomy: a prospective, randomized, placebo-controlled trial. Br J Anaesth. 2014 Jun;112(6):1075-82. doi: 10.1093/bja/aeu001. Epub 2014 Feb 26.</citation>
    <PMID>24576720</PMID>
  </results_reference>
  <results_reference>
    <citation>Yan B, Li K, Xu J, Wang W, Li K, Liu H, Shan B, Tang X. Acupoint-specific fMRI patterns in human brain. Neurosci Lett. 2005 Aug 5;383(3):236-40.</citation>
    <PMID>15876491</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2019</study_first_posted>
  <last_update_submitted>April 10, 2019</last_update_submitted>
  <last_update_submitted_qc>April 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Zhihong LU</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

